Cytheris

Fact Sheet
DOWNLOAD CORPORATE
FACT SHEET (PDF)


 
News Room


Cytheris 1
Press Releases 2010

June 7, 2010

In English Cytheris Closes €12 Million ($15 Million) Series D Financing
In French

March 16, 2010

In English Cytheris Announces Publication of Preclinical Study in Journal of Immunology Showing Interleukin-7 Promotes T Cell Viability, Trafficking, and Functionality While Improving Survival in Sepsis
In French

February 2, 2010

In English Cytheris Announces Notice of Allowance for U.S. Patent Covering the Preparation and Uses of its Glycosylated Recombinant Human Interleukin-7 (CYT107)
In French

January 12, 2010

In English Cytheris Initiates INSPIRE 2, a Phase II Clinical Trial of Recombinant Human Interleukin-7 (CYT107) in Chronically Infected HIV Patients Who Fail to Achieve Optimal Immune Reconstitution under HAART Therapy
In French

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

News Archive

Press 2009

Press 2008

Press 2007

Press 2006

Press 2005

Press 2004

Press 2002
Home   About Cytheris   Science   Pipeline & Products   Clinical Trials   Business Development   News Room  Careers   Contact Us   
Sitemap   Privacy Policy   Terms of Use   © 2010 Cytheris, Inc. All rights reserved.